Глава 7. Терапия антидепрессантами 329

depressive disorder. Psychopharmacol Bull 1986; 22 (1): 186-191.

108. Hicks F, Robins E, Murphy G. Comparison of adinazolam, amitriptyline, and placebo in the treatment of melancholic depression. Psychia­try Res 1987; 23: 221-227.

109. Gundlach R, Engelhardt DM, Hankoff L, et al. A double-blind outpatient study of diazepam (Va-lium) and placebo. Psychopharmacologia 1966; 9:81-92.

110. McDowall A, Owen S, Robin AA. A controlled comparison of diazepam and amylobarbitone in anxiety states. BrJ Psychiatry 1966; 112:629-631.

111. Rao AV. A controlled trial with "Valium" in ob­sessive compulsive state. J Indian Med Assoc 1967; 42: 564-567.

112. Hall RCW, Joffe JR. Aberrant response to dia­zepam: a new syndrome. Am J Psychiatry 1972; 129:738-742.

113. Lader MH, Petursson. Benzodiazepine deriva­tives-side effects and dangers. Biol Psychiatry 1981; 16:1195-1201.

114. Fontaine R, Annable L, Chouinard G, et al. Bro-mazepam and diazepam in generalized anxiety: a placebo-controlled study with measurement of drug plasma concentrations. J Clin Psycho­pharmacol 1983; 3: 80-87.

115. Wilkinson CJ. Effects of diazepam (Valium) and trait anxiety on human physical aggression and emotional state. J Behav Med 1985; 8: 101-114.

116. Fontaine R, Mercier P, Beaudry P, et al. Broma-zepam and lorazepam in generalized anxiety: a placebo-controlled study with measurement of drug plasma concentrations. Acta Psychiatr Scand 1986; 74: 451-458.

117. Pollack MH, Tesar GE, Rosenbaum JF, et al. Clo-nazepam in the treatment of panic disorder and agoraphobia: a one-year follow-up. J Clin Psy­chopharmacol 1986; 47: 475-476.

118. Lydiard RB, Laraia MT, Ballenger JC, Howell EF. Emergence of depressive symptoms in patients receiving alprazolam for panic disorder. Am J Psychiatry 1987; 144: 664-665.

119. Lydiard RB, Howell EF, Laraia MT, et al. Depres­sion in patients receiving lorazepam for panic. Am J Psychiatry 1989; 146; 629-631.

120. Stramentinoli G, Caho E, Alger S. The increase in SAMe concentration in rat brain after its sys-

temic administration. Comm Psychopharmacol 1977; 1: 89-97.

121. Janicak P, Lipinski J, Davis JM, Altman E, Shar-ma RP. Parenteral SAMe in depression: literature review and preliminary data. Psychopharmacol Bull 1989; 25(2): 238-242.

122. Perry PJ, Pfohl BM, Holstad SG. The relationship between antidepressant response and TCA plas­ma concentrations. Clin Pharmacokinet 1987; 13:381-392.

123. Taylor D, Carter R, Eison A, et al. Pharmacology and neurochemistry of nefazodone, a novel anti-depressant drug. J Clin Psychiatry 1995; 56 (Sup-pi 6): 3-Й.

124. Eison A, Eison M, Torrente J, et al. Nefazodone: preclinical pharmacology of a new antidepres­sant. Psychopharmacol Bull 1990; 26: 311-315.

125. Salazar D, Chaikin P, Swanson B, et al. The ef­fects of nefazodone and fluoxetme on platelet serotonin uptake and whole blood serotonin. Clin Pharmacol Ther 1994; 55:137.

126. Nies A. Monoamine oxidase inhibitors. In: Paykel ES, ed. Handbook of affective disorders. New York: Guilford Press, 1982.

127. Coplan JD, Gorman JM. Detectable levels of fluoxetine metabolites after discontinuation: an unexpected serotonin syndrome. Am J Psychia­try 1993; 150 (5): 837.

128. Feighner JP, Boyer WE, Tyler DL, Nebrosky RJ. Adverse consequences of fluoxetine-MAOl com­bination therapy. J Clin Psychiatry 1990; 51(6): 222-225.

129. Preskorn SH. Selection of an antidepressant: Mir-tazapine. J Clin Psychiatry 1997; (in press).

130. Frazer A, Antidepressants. J Clin Psychiatry 1997; (in press).

131. Zivkov M, Roes KCB, Pols AB. Efficacy of Org 3770 (mirtazapine) vs. amitriptyline in patients with major depressive disorder: a meta-analysis. Hum Psychopharmacology 1995; 10: S135-S145.

132. Fawcett JA, Barkin R. Efficacy issues with anti-depressants. J Clin Psychiatry 1997; (in press).

133. Catterson M, Preskorn SH. Double-blind cross­over study of mirtazapine, amitriptyline, and placebo in patients with major depression. In: New Research Program and Abstracts of the 149th annual meeting of the American Psychi­atric Association; May 6,1996; NewYork, NY. Ab­stract NR157.